Cancer Research Cancer Epigenetics  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 5187-5190, November 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waldman, T.
Right arrow Articles by Vogelstein, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waldman, T.
Right arrow Articles by Vogelstein, B.

p21 Is Necessary for the p53-mediated G1 Arrest in Human Cancer Cells1

Todd Waldman, Kenneth W. Kinzler and Bert Vogelstein2

The Johns Hopkins Oncology Center and the Program in Human Genetics and Molecular Biology, Baltimore, Maryland 21231 [T. W., K. W. K., B. V.], and The Howard Hughes Medical Institute, Baltimore, Maryland 21231 [B. V.]

DNA-damaging agents induce a p53-dependent G1 arrest that may be critical for p53-mediated tumor suppression. It has been suggested that p21WAF1/CIP1, a cdk inhibitory protein transcriptionally regulated by p53, is an effector of this arrest. To test this hypothesis, an isogenic set of human colon adenocarcinoma cell lines differing only in their p21 status was created. The parental cell line underwent the expected cell cycle changes upon induction of p53 expression by DNA damage, but the G1 arrest was completely abrogated in p21-deficient cells. These results unambiguously establish p21 as a critical mediator of one well-documented p53 function and have important implications for understanding cell cycle checkpoints and the mechanism(s) through which p53 inhibits human neoplasia.

1 This work was supported by NIH Grants CA43460 and GM07184. B. V. is an Investigator of the Howard Hughes Medical Institute.

2 To whom requests for reprints should be addressed, at The Johns Hopkins Oncology Center, 424 North Bond Street, Baltimore, MD 21231. Phone: (410) 955-8878; Fax (410) 955-0548.

Received 9/12/95. Accepted 10/ 5/95.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
Y. Li, L.-J. Li, S.-T. Zhang, L.-J. Wang, Z. Zhang, N. Gao, Y.-Y. Zhang, and Q.-M. Chen
In vitro and Clinical Studies of Gene Therapy with Recombinant Human Adenovirus-p53 Injection for Oral Leukoplakia
Clin. Cancer Res., November 1, 2009; 15(21): 6724 - 6731.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
C.-H. Lim, S.-W. Chong, and Y.-J. Jiang
Udu Deficiency Activates DNA Damage Checkpoint
Mol. Biol. Cell, October 1, 2009; 20(19): 4183 - 4193.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
D. Gao, H. Inuzuka, M. Korenjak, A. Tseng, T. Wu, L. Wan, M. Kirschner, N. Dyson, and W. Wei
Cdh1 Regulates Cell Cycle through Modulating the Claspin/Chk1 and the Rb/E2F1 Pathways
Mol. Biol. Cell, July 15, 2009; 20(14): 3305 - 3316.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Ubezio, M. Lupi, D. Branduardi, P. Cappella, E. Cavallini, V. Colombo, G. Matera, C. Natoli, D. Tomasoni, and M. D'Incalci
Quantitative Assessment of the Complex Dynamics of G1, S, and G2-M Checkpoint Activities
Cancer Res., June 15, 2009; 69(12): 5234 - 5240.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. F. Calvisi, H. Donninger, M. D. Vos, M. J. Birrer, L. Gordon, V. Leaner, and G. J. Clark
NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53
Cancer Res., June 1, 2009; 69(11): 4629 - 4637.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Liu, N. Bellam, H.-Y. Lin, B. Wang, C. R. Stockard, W. E. Grizzle, and W.-C. Lin
Regulation of p53 by TopBP1: a Potential Mechanism for p53 Inactivation in Cancer
Mol. Cell. Biol., May 15, 2009; 29(10): 2673 - 2693.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
V. C. Padmakumar, E. Aleem, C. Berthet, M. B. Hilton, and P. Kaldis
Cdk2 and Cdk4 Activities Are Dispensable for Tumorigenesis Caused by the Loss of p53
Mol. Cell. Biol., May 15, 2009; 29(10): 2582 - 2593.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Mannefeld, E. Klassen, and S. Gaubatz
B-MYB Is Required for Recovery from the DNA Damage-Induced G2 Checkpoint in p53 Mutant Cells
Cancer Res., May 1, 2009; 69(9): 4073 - 4080.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. E. Toettcher, A. Loewer, G. J. Ostheimer, M. B. Yaffe, B. Tidor, and G. Lahav
Distinct mechanisms act in concert to mediate cell cycle arrest
PNAS, January 20, 2009; 106(3): 785 - 790.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Song, Y. Wang, K. Kudo, E. J. Gavin, Y. Xi, and J. Ju
miR-192 Regulates Dihydrofolate Reductase and Cellular Proliferation through the p53-microRNA Circuit
Clin. Cancer Res., December 15, 2008; 14(24): 8080 - 8086.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Zhang, L. Shu, and X. Chen
Syntaxin 6, a Regulator of the Protein Trafficking Machinery and a Target of the p53 Family, Is Required for Cell Adhesion and Survival
J. Biol. Chem., November 7, 2008; 283(45): 30689 - 30698.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
B. S. Min, Y. J. Choi, H. R. Pyo, H. Kim, J. Seong, H. C. Chung, S. Y. Rha, and N. K. Kim
Cyclooxygenase-2 Expression in Pretreatment Biopsy as a Predictor of Tumor Responses After Preoperative Chemoradiation in Rectal Cancer
Arch Surg, November 1, 2008; 143(11): 1091 - 1097.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Rodriguez, L. T. Hansen, G. Phear, J. Scorah, M. Spang-Thomsen, A. Cox, T. Helleday, and M. Meuth
Thymidine Selectively Enhances Growth Suppressive Effects of Camptothecin/Irinotecan in MSI+ Cells and Tumors Containing a Mutation of MRE11
Clin. Cancer Res., September 1, 2008; 14(17): 5476 - 5483.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Lazzarini, S. Moretti, S. Orecchia, P.-G. Betta, A. Procopio, and A. Catalano
Enhanced Antitumor Therapy by Inhibition of p21waf1 in Human Malignant Mesothelioma
Clin. Cancer Res., August 15, 2008; 14(16): 5099 - 5107.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. Egler, S. Korur, M. Failly, J.-L. Boulay, R. Imber, M. M. Lino, and A. Merlo
Histone Deacetylase Inhibition and Blockade of the Glycolytic Pathway Synergistically Induce Glioblastoma Cell Death
Clin. Cancer Res., May 15, 2008; 14(10): 3132 - 3140.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. Ivanovska, A. S. Ball, R. L. Diaz, J. F. Magnus, M. Kibukawa, J. M. Schelter, S. V. Kobayashi, L. Lim, J. Burchard, A. L. Jackson, et al.
MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression
Mol. Cell. Biol., April 1, 2008; 28(7): 2167 - 2174.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Zhou, Y. Zhong, Y. Wang, X. Zhang, D. L. Batista, R. Gejman, P. J. Ansell, J. Zhao, C. Weng, and A. Klibanski
Activation of p53 by MEG3 Non-coding RNA
J. Biol. Chem., August 24, 2007; 282(34): 24731 - 24742.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. D. Scott, S. Nath-Sain, M. D. Agnew, and P. A. Marignani
LKB1 Catalytically Deficient Mutants Enhance Cyclin D1 Expression
Cancer Res., June 15, 2007; 67(12): 5622 - 5627.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. E. Giono and J. J. Manfredi
Mdm2 Is Required for Inhibition of Cdk2 Activity by p21, Thereby Contributing to p53-Dependent Cell Cycle Arrest
Mol. Cell. Biol., June 1, 2007; 27(11): 4166 - 4178.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
D. Michod and C. Widmann
TAT-RasGAP317-326 Requires p53 and PUMA to Sensitize Tumor Cells to Genotoxins
Mol. Cancer Res., May 1, 2007; 5(5): 497 - 507.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. K. Donawho, Y. Luo, Y. Luo, T. D. Penning, J. L. Bauch, J. J. Bouska, V. D. Bontcheva-Diaz, B. F. Cox, T. L. DeWeese, L. E. Dillehay, et al.
ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models
Clin. Cancer Res., May 1, 2007; 13(9): 2728 - 2737.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Aneja, A. M. Ghaleb, J. Zhou, V. W. Yang, and H. C. Joshi
p53 and p21 Determine the Sensitivity of Noscapine-Induced Apoptosis in Colon Cancer Cells
Cancer Res., April 15, 2007; 67(8): 3862 - 3870.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Hosokawa, A. Takehara, K. Matsuda, H. Eguchi, H. Ohigashi, O. Ishikawa, Y. Shinomura, K. Imai, Y. Nakamura, and H. Nakagawa
Oncogenic Role of KIAA0101 Interacting with Proliferating Cell Nuclear Antigen in Pancreatic Cancer
Cancer Res., March 15, 2007; 67(6): 2568 - 2576.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Wang, J. Yu, and L. Zhang
The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage
PNAS, March 6, 2007; 104(10): 4054 - 4059.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Liekens, S. Gijsbers, E. Vanstreels, D. Daelemans, E. De Clercq, and S. Hatse
The Nucleotide Analog Cidofovir Suppresses Basic Fibroblast Growth Factor (FGF2) Expression and Signaling and Induces Apoptosis in FGF2-Overexpressing Endothelial Cells
Mol. Pharmacol., March 1, 2007; 71(3): 695 - 703.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. A. Barboza, G. Liu, Z. Ju, A. K. El-Naggar, and G. Lozano
p21 delays tumor onset by preservation of chromosomal stability
PNAS, December 26, 2006; 103(52): 19842 - 19847.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J.-H. Lee, J.-S. Lee, S.-E. Kim, B.-S. Moon, Y.-C. Kim, S.-K. Lee, S.-K. Lee, and K.-Y. Choi
Tautomycetin inhibits growth of colorectal cancer cells through p21cip/WAF1 induction via the extracellular signal-regulated kinase pathway
Mol. Cancer Ther., December 1, 2006; 5(12): 3222 - 3231.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. R. Saunders and E. Verdin
Ornithine decarboxylase activity in tumor cell lines correlates with sensitivity to cell death induced by histone deacetylase inhibitors.
Mol. Cancer Ther., November 1, 2006; 5(11): 2777 - 2785.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. K. Agarwal, K. Hastak, M. W. Jackson, S. N. Breit, G. R. Stark, and M. L. Agarwal
Macrophage inhibitory cytokine 1 mediates a p53-dependent protective arrest in S phase in response to starvation for DNA precursors
PNAS, October 31, 2006; 103(44): 16278 - 16283.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Zhang, R. B. Hamanaka, E. Bobrovnikova-Marjon, J. D. Gordan, M.-S. Dai, H. Lu, M. C. Simon, and J. A. Diehl
Ribosomal Stress Couples the Unfolded Protein Response to p53-dependent Cell Cycle Arrest
J. Biol. Chem., October 6, 2006; 281(40): 30036 - 30045.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Aiello, G. Pandini, F. Frasca, E. Conte, A. Murabito, A. Sacco, M. Genua, R. Vigneri, and A. Belfiore
Peroxisomal Proliferator-Activated Receptor-{gamma} Agonists Induce Partial Reversion of Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer Cells
Endocrinology, September 1, 2006; 147(9): 4463 - 4475.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Hubert, S. Paris, J.-P. Piret, N. Ninane, M. Raes, and C. Michiels
Casein kinase 2 inhibition decreases hypoxia-inducible factor-1 activity under hypoxia through elevated p53 protein level
J. Cell Sci., August 15, 2006; 119(16): 3351 - 3362.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Eckert, S. E. M. Meek, and K. L. Ball
A Novel Repressor Domain Is Required for Maximal Growth Inhibition by the IRF-1 Tumor Suppressor
J. Biol. Chem., August 11, 2006; 281(32): 23092 - 23102.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C.-H. Chao, C.-M. Chen, P.-L. Cheng, J.-W. Shih, A.-P. Tsou, and Y.-H. Wu Lee
DDX3, a DEAD Box RNA Helicase with Tumor Growth-Suppressive Property and Transcriptional Regulation Activity of the p21waf1/cip1 Promoter, Is a Candidate Tumor Suppressor.
Cancer Res., July 1, 2006; 66(13): 6579 - 6588.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
A. Rossi, R. Mukerjee, P. Ferrante, K. Khalili, S. Amini, and B. E. Sawaya
Human immunodeficiency virus type 1 Tat prevents dephosphorylation of Sp1 by TCF-4 in astrocytes
J. Gen. Virol., June 1, 2006; 87(6): 1613 - 1623.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Xi, R. Shalgi, O. Fodstad, Y. Pilpel, and J. Ju
Differentially Regulated Micro-RNAs and Actively Translated Messenger RNA Transcripts by Tumor Suppressor p53 in Colon Cancer.
Clin. Cancer Res., April 1, 2006; 12(7): 2014 - 2024.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R.A. Crallan, N.T. Georgopoulos, and J. Southgate
Experimental models of human bladder carcinogenesis
Carcinogenesis, March 1, 2006; 27(3): 374 - 381.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Menendez, O. Krysiak, A. Inga, B. Krysiak, M. A. Resnick, and G. Schonfelder
A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network
PNAS, January 31, 2006; 103(5): 1406 - 1411.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Y. Archer, J. Johnson, H.-J. Kim, Q. Ma, H. Mou, V. Daesety, S. Meng, and R. A. Hodin
The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells
Am J Physiol Gastrointest Liver Physiol, October 1, 2005; 289(4): G696 - G703.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. C. Shen, H. Heng, Y. Wang, S. Lu, G. Liu, C.-X. Deng, S.C. Brooks, and Y. A. Wang
ATM and p21 Cooperate to Suppress Aneuploidy and Subsequent Tumor Development
Cancer Res., October 1, 2005; 65(19): 8747 - 8753.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-V. Le, A. J. Minn, and J. Massague
Cyclin-dependent Kinase Inhibitors Uncouple Cell Cycle Progression from Mitochondrial Apoptotic Functions in DNA-damaged Cancer Cells
J. Biol. Chem., September 9, 2005; 280(36): 32018 - 32025.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W.-S. Xu, G. Perez, L. Ngo, C.-Y. Gui, and P. A. Marks
Induction of Polyploidy by Histone Deacetylase Inhibitor: A Pathway for Antitumor Effects
Cancer Res., September 1, 2005; 65(17): 7832 - 7839.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. C. Arva, T. R. Gopen, K. E. Talbott, L. E. Campbell, A. Chicas, D. E. White, G. L. Bond, A. J. Levine, and J. Bargonetti
A Chromatin-associated and Transcriptionally Inactive p53-Mdm2 Complex Occurs in mdm2 SNP309 Homozygous Cells
J. Biol. Chem., July 22, 2005; 280(29): 26776 - 26787.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. D. Choudhury, H. Xu, A. P. Modi, W. Zhang, T. Ludwig, and R. Baer
Hyperphosphorylation of the BARD1 Tumor Suppressor in Mitotic Cells
J. Biol. Chem., July 1, 2005; 280(26): 24669 - 24679.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. L. Gartel and S. K. Radhakrishnan
Lost in Transcription: p21 Repression, Mechanisms, and Consequences
Cancer Res., May 15, 2005; 65(10): 3980 - 3985.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Arbel-Goren, Y. Levy, D. Ronen, and Y. Zick
Cyclin-dependent Kinase Inhibitors and JNK Act as Molecular Switches, Regulating the Choice between Growth Arrest and Apoptosis Induced by Galectin-8
J. Biol. Chem., May 13, 2005; 280(19): 19105 - 19114.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. F. Aguero, M. M. Facchinetti, Z. Sheleg, and A. M. Senderowicz
Phenoxodiol, a Novel Isoflavone, Induces G1 Arrest by Specific Loss in Cyclin-Dependent Kinase 2 Activity by p53-Independent Induction of p21WAF1/CIP1
Cancer Res., April 15, 2005; 65(8): 3364 - 3373.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Normand, P. G. Hemmati, B. Verdoodt, C. von Haefen, J. Wendt, D. Guner, E. May, B. Dorken, and P. T. Daniel
p14ARF Induces G2 Cell Cycle Arrest in p53- and p21-deficient Cells by Down-regulating p34cdc2 Kinase Activity
J. Biol. Chem., February 25, 2005; 280(8): 7118 - 7130.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Choi, E. W. Gerner, L. Ramdas, J. Dupart, J. Carew, L. Proctor, P. Huang, W. Zhang, and S. R. Hamilton
Combination of 5-Fluorouracil and N1,N11-Diethylnorspermine Markedly Activates Spermidine/Spermine N1-Acetyltransferase Expression, Depletes Polyamines, and Synergistically Induces Apoptosis in Colon Carcinoma Cells
J. Biol. Chem., February 4, 2005; 280(5): 3295 - 3304.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Yoon and R. C. Smart
C/EBP{alpha} Is a DNA Damage-Inducible p53-Regulated Mediator of the G1 Checkpoint in Keratinocytes
Mol. Cell. Biol., December 15, 2004; 24(24): 10650 - 10660.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L.-h. Meng, H. Zhang, L. Hayward, H. Takemura, R.-G. Shao, and Y. Pommier
Tetrandrine Induces Early G1 Arrest in Human Colon Carcinoma Cells by Down-Regulating the Activity and Inducing the Degradation of G1-S-Specific Cyclin-Dependent Kinases and by Inducing p53 and p21Cip1
Cancer Res., December 15, 2004; 64(24): 9086 - 9092.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Benimetskaya, J. C. Lai, A. Khvorova, S. Wu, E. Hua, P. Miller, L.-M. Zhang, and C. A. Stein
Relative Bcl-2 Independence of Drug-Induced Cytotoxicity and Resistance in 518A2 Melanoma Cells
Clin. Cancer Res., December 15, 2004; 10(24): 8371 - 8379.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Amini, M. Saunders, K. Kelley, K. Khalili, and B. E. Sawaya
Interplay between HIV-1 Vpr and Sp1 Modulates p21WAF1 Gene Expression in Human Astrocytes
J. Biol. Chem., October 29, 2004; 279(44): 46046 - 46056.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. J. Rorie and B. E. Weissman
The Ews/Fli-1 Fusion Gene Changes the Status of p53 in Neuroblastoma Tumor Cell Lines
Cancer Res., October 15, 2004; 64(20): 7288 - 7295.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Song, J. Cooperman, D. L. Letting, G. A. Blobel, and J. K. Choi
Identification of Cyclin D3 as a Direct Target of E2A Using DamID
Mol. Cell. Biol., October 1, 2004; 24(19): 8790 - 8802.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Lee, J.-S. Kim, and T. Waldman
PTEN Gene Targeting Reveals a Radiation-Induced Size Checkpoint in Human Cancer Cells
Cancer Res., October 1, 2004; 64(19): 6906 - 6914.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. A. Amundson, M. B. Grace, C. B. McLeland, M. W. Epperly, A. Yeager, Q. Zhan, J. S. Greenberger, and A. J. Fornace Jr.
Human In vivo Radiation-Induced Biomarkers: Gene Expression Changes in Radiotherapy Patients
Cancer Res., September 15, 2004; 64(18): 6368 - 6371.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Bai, H. Nakamura, S. Ueda, Y.-W. Kwon, T. Tanaka, S. Ban, and J. Yodoi
Proteasome-dependent Degradation of Cyclin D1 in 1-Methyl-4-phenylpyridinium Ion (MPP+)-induced Cell Cycle Arrest
J. Biol. Chem., September 10, 2004; 279(37): 38710 - 38714.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. I. Geller, K. Szekely-Szucs, I. Petak, B. Doyle, and J. A. Houghton
P21Cip1 Is a Critical Mediator of the Cytotoxic Action of Thymidylate Synthase Inhibitors in Colorectal Carcinoma Cells
Cancer Res., September 1, 2004; 64(17): 6296 - 6303.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Guweidhi, J. Kleeff, N. Giese, J. E. Fitori, K. Ketterer, T. Giese, M. W. Buchler, M. Korc, and H. Friess
Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis
Carcinogenesis, September 1, 2004; 25(9): 1575 - 1585.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. G. Iyer, S.-F. Chin, H. Ozdag, Y. Daigo, D.-E. Hu, M. Cariati, K. Brindle, S. Aparicio, and C. Caldas
p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels
PNAS, May 11, 2004; 101(19): 7386 - 7391.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. C. Tu, T. Melendy, and T. A. Beerman
DNA damage responses triggered by a highly cytotoxic monofunctional DNA alkylator, hedamycin, a pluramycin antitumor antibiotic
Mol. Cancer Ther., May 1, 2004; 3(5): 577 - 586.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. F. Shariat, H. Tokunaga, J. Zhou, J. Kim, G. E. Ayala, W. F. Benedict, and S. P. Lerner
p53, p21, pRB, and p16 Expression Predict Clinical Outcome in Cystectomy With Bladder Cancer
J. Clin. Oncol., March 15, 2004; 22(6): 1014 - 1024.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. E. A. LaRue, M. Khalil, and J. P. Freyer
Microenvironmental Regulation of Proliferation in Multicellular Spheroids Is Mediated through Differential Expression of Cyclin-Dependent Kinase Inhibitors
Cancer Res., March 1, 2004; 64(5): 1621 - 1631.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Prince, S. Carreira, K. W. Vance, A. Abrahams, and C. R. Goding
Tbx2 Directly Represses the Expression of the p21WAF1 Cyclin-Dependent Kinase Inhibitor
Cancer Res., March 1, 2004; 64(5): 1669 - 1674.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Kim, S. Kook, D. J. Kim, C. Teodorof, and W. K. Song
The 31-kDa Caspase-generated Cleavage Product of p130cas Functions as a Transcriptional Repressor of E2A in Apoptotic Cells
J. Biol. Chem., February 27, 2004; 279(9): 8333 - 8342.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. S. Yoon and V. W. Yang
Requirement of Kruppel-like Factor 4 in Preventing Entry into Mitosis following DNA Damage
J. Biol. Chem., February 6, 2004; 279(6): 5035 - 5041.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Wajapeyee and K. Somasundaram
Cell Cycle Arrest and Apoptosis Induction by Activator Protein 2{alpha} (AP-2{alpha}) and the Role of p53 and p21WAF1/CIP1 in AP-2{alpha}-mediated Growth Inhibition
J. Biol. Chem., December 26, 2003; 278(52): 52093 - 52101.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Yu, X.-W. Liu, and H.-R. C. Kim
Platelet-derived Growth Factor (PDGF) Receptor-{alpha}-activated c-Jun NH2-terminal Kinase-1 Is Critical for PDGF-induced p21WAF1/CIP1 Promoter Activity Independent of p53
J. Biol. Chem., December 5, 2003; 278(49): 49582 - 49588.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Maitra, D. E. Hansel, P. Argani, R. Ashfaq, A. Rahman, A. Naji, S. Deng, J. Geradts, L. Hawthorne, M. G. House, et al.
Global Expression Analysis of Well-Differentiated Pancreatic Endocrine Neoplasms Using Oligonucleotide Microarrays
Clin. Cancer Res., December 1, 2003; 9(16): 5988 - 5995.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Ishizuka, K. Martin, C. Booth, C. S. Potten, G. de Murcia, A. Burkle, and T. B. L. Kirkwood
Poly(ADP-ribose) polymerase-1 is a survival factor for radiation-exposed intestinal epithelial stem cells in vivo
Nucleic Acids Res., November 1, 2003; 31(21): 6198 - 6205.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Ukomadu and A. Dutta
p21-dependent Inhibition of Colon Cancer Cell Growth by Mevastatin Is Independent of Inhibition of G1 Cyclin-dependent Kinases
J. Biol. Chem., October 31, 2003; 278(44): 43586 - 43594.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Su, S. Ishikawa, M. Kojima, and B. Liu
Eradication of pathogenic {beta}-catenin by Skp1/Cullin/F box ubiquitination machinery
PNAS, October 28, 2003; 100(22): 12729 - 12734.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Li, J.-Y. Zhou, Y. Ge, L. H. Matherly, and G. S. Wu
The Phosphatase MKP1 Is a Transcriptional Target of p53 Involved in Cell Cycle Regulation
J. Biol. Chem., October 17, 2003; 278(42): 41059 - 41068.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. J. Barnes, M. J. Kellum, K. E. Pinder, J. A. Frisancho, and P. M. Pitha
Interferon Regulatory Factor 5, a Novel Mediator of Cell Cycle Arrest and Cell Death
Cancer Res., October 1, 2003; 63(19): 6424 - 6431.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Di Padova, T. Bruno, F. De Nicola, S. Iezzi, C. D'Angelo, R. Gallo, D. Nicosia, N. Corbi, A. Biroccio, A. Floridi, et al.
Che-1 Arrests Human Colon Carcinoma Cell Proliferation by Displacing HDAC1 from the p21WAF1/CIP1 Promoter
J. Biol. Chem., September 19, 2003; 278(38): 36496 - 36504.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Bai, J. H. Xi, E. F. Wawrousek, T. P. Fleming, and U. P. Andley
Hyperproliferation and p53 Status of Lens Epithelial Cells Derived from {alpha}B-crystallin Knockout Mice
J. Biol. Chem., September 19, 2003; 278(38): 36876 - 36886.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. Nowak, P. M. Price, and R. G. Schnellmann
Lack of a functional p21WAF1/CIP1 gene accelerates caspase-independent apoptosis induced by cisplatin in renal cells
Am J Physiol Renal Physiol, September 1, 2003; 285(3): F440 - F450.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Efferth, A. Sauerbrey, A. Olbrich, E. Gebhart, P. Rauch, H. O. Weber, J. G. Hengstler, M.-E. Halatsch, M. Volm, K. D. Tew, et al.
Molecular Modes of Action of Artesunate in Tumor Cell Lines
Mol. Pharmacol., August 1, 2003; 64(2): 382 - 394.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Zeng, Y. Zhang, S. Chien, X. Liu, and J. Y.-J. Shyy
The Role of p53 Deacetylation in p21Waf1 Regulation by Laminar Flow
J. Biol. Chem., June 27, 2003; 278(27): 24594 - 24599.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
N. T.V. Le and D. R. Richardson
Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1, but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation
Carcinogenesis, June 1, 2003; 24(6): 1045 - 1058.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. V. Jallepalli, C. Lengauer, B. Vogelstein, and F. Bunz
The Chk2 Tumor Suppressor Is Not Required for p53 Responses in Human Cancer Cells
J. Biol. Chem., May 30, 2003; 278(23): 20475 - 20479.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Ahn, M. Urist, and C. Prives
Questioning the Role of Checkpoint Kinase 2 in the p53 DNA Damage Response
J. Biol. Chem., May 30, 2003; 278(23): 20480 - 20489.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. M. Douglas and G. G. Haddad
Genetic Models in Applied Physiology: Invited Review: Effect of oxygen deprivation on cell cycle activity: a profile of delay and arrest
J Appl Physiol, May 1, 2003; 94(5): 2068 - 2083.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. D. Braastad, Z. Han, and E. A. Hendrickson
Constitutive DNase I Hypersensitivity of p53-Regulated Promoters
J. Biol. Chem., February 28, 2003; 278(10): 8261 - 8268.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Yu, Z. Wang, K. W. Kinzler, B. Vogelstein, and L. Zhang
PUMA mediates the apoptotic response to p53 in colorectal cancer cells
PNAS, February 18, 2003; 100(4): 1931 - 1936.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H.-L. Yang, J.-X. Pan, L. Sun, and S.-C. J. Yeung
p21 Waf-1 (Cip-1) Enhances Apoptosis Induced by Manumycin and Paclitaxel in Anaplastic Thyroid Cancer Cells
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 763 - 772.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Wang, J. Gu, K. Judson-Kremer, K.L. Powell, H. Mistry, P. Simhambhatla, C. M. Aldaz, S. Gaddis, and M. C. MacLeod
Response of human mammary epithelial cells to DNA damage induced by BPDE: involvement of novel regulatory pathways
Carcinogenesis, February 1, 2003; 24(2): 225 - 234.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. S. Yoon, X. Chen, and V. W. Yang
Kruppel-like Factor 4 Mediates p53-dependent G1/S Cell Cycle Arrest in Response to DNA Damage
J. Biol. Chem., January 17, 2003; 278(4): 2101 - 2105.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Polager and D. Ginsberg
E2F Mediates Sustained G2 Arrest and Down-regulation of Stathmin and AIM-1 Expression in Response to Genotoxic Stress
J. Biol. Chem., January 10, 2003; 278(3): 1443 - 1449.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. C. Polek, L. V. Stewart, E. J. Ryu, M. B. Cohen, E. A. Allegretto, and N. L. Weigel
p53 Is Required for 1,25-Dihydroxyvitamin D3-Induced G0 Arrest But Is Not Required for G1 Accumulation or Apoptosis of LNCaP Prostate Cancer Cells
Endocrinology, January 1, 2003; 144(1): 50 - 60.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Russo, D. Arzani, S. Trombino, and C. Falugi
c-myc Down-Regulation Induces Apoptosis in Human Cancer Cell Lines Exposed to RPR-115135 (C31H29NO4), a Non-Peptidomimetic Farnesyltransferase Inhibitor
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 37 - 47.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. McPherson, A. V. Loktev, and R. J. Weigel
Tumor Suppressor Activity of AP2alpha Mediated through a Direct Interaction with p53
J. Biol. Chem., November 15, 2002; 277(47): 45028 - 45033.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Mauser, S.'i. Saito, E. Appella, C. W. Anderson, W. T. Seaman, and S. Kenney
The Epstein-Barr Virus Immediate-Early Protein BZLF1 Regulates p53 Function through Multiple Mechanisms
J. Virol., November 13, 2002; 76(24): 12503 - 12512.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. A. Martinez, I. Naguibneva, H. Lehrmann, A. Vervisch, T. Tchenio, G. Lozano, and A. Harel-Bellan
Synthetic small inhibiting RNAs: Efficient tools to inactivate oncogenic mutations and restore p53 pathways
PNAS, November 12, 2002; 99(23): 14849 - 14854.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Zhang, X. Shi, Q.-J. Zhang, M. Hampong, H. Paddon, D. Wahyuningsih, and S. Pelech
Nocodazole-induced p53-dependent c-Jun N-terminal Kinase Activation Reduces Apoptosis in Human Colon Carcinoma HCT116 Cells
J. Biol. Chem., November 8, 2002; 277(46): 43648 - 43658.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Leger and E. A. Drobetsky
Modulation of the DNA damage response in UV-exposed human lymphoblastoid cells through genetic-versus functional-inactivation of the p53 tumor suppressor
Carcinogenesis, October 1, 2002; 23(10): 1631 - 1640.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M.-H. Pan, W.-J. Chen, S.-Y. Lin-Shiau, C.-T. Ho, and J.-K. Lin
Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells
Carcinogenesis, October 1, 2002; 23(10): 1677 - 1684.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Megyesi, L. Andrade, J. M. Vieira Jr., R. L. Safirstein, and P. M. Price
Coordination of the cell cycle is an important determinant of the syndrome of acute renal failure
Am J Physiol Renal Physiol, October 1, 2002; 283(4): F810 - F816.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Javelaud and F. Besancon
Inactivation of p21WAF1Sensitizes Cells to Apoptosis via an Increase of Both p14ARF and p53 Levels and an Alteration of the Bax/Bcl-2 Ratio
J. Biol. Chem., September 27, 2002; 277(40): 37949 - 37954.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.